Cystectomy in Patients With Spinal Cord Injury: Indications and Long-Term Outcomes

Journal of Urology

Volumn 184, Issue 1, 2010, Pages 92-98

  Cheng, Janice N ^a   Lawrentschuk, Nathan ^a   Gyomber, Dennis ^a   Rogerson, John ^a   Bolton, Damien M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

cystectomy; spinal cord injuries; surgical procedures, operative; treatment outcome; urinary bladder neoplasms

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER SURGERY; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTECTOMY; DATA BASE; DATA COLLECTION METHOD; DEATH; DEMOGRAPHY; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PATHOLOGY; PATIENT SATISFACTION; PERIOPERATIVE PERIOD; POPULATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PYELONEPHRITIS; RATING SCALE; RECURRENCE RISK; SPINAL CORD INJURY; SURVIVAL; SURVIVOR; TREATMENT INDICATION; TREATMENT OUTCOME; URINARY TRACT INFECTION; UROLOGY;

ADULT; AGED; BCG VACCINE; CYSTECTOMY; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; SMOKING; SPINAL CORD INJURIES; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 77953120976     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.03.014     Document Type: Article

References (30)

1. Samson G., and Cardenas D.D. Neurogenic bladder in spinal cord injury. Phys Med Rehabil Clin N Am 18 (2007) 255
2. West D.A., Cummings J.M., Longo W.E., et al. Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injury. Urology 53 (1999) 292
3. Bickel A., Culkin D.J., and Wheeler Jr. J.S. Bladder cancer in spinal cord injury patients. J Urol 146 (1991) 1240
4. Groah S.L., Weitzenkamp D.A., Lammertse D.P., et al. Excess risk of bladder cancer in spinal cord injury: evidence for an association between indwelling catheter use and bladder cancer. Arch Phys Med Rehabil 83 (2002) 346
5. Subramonian K., Cartwright R.A., Harnden P., et al. Bladder cancer in patients with spinal cord injuries. BJU Int 93 (2004) 739
6. Groah S.L., and Lammertse D.P. Factors associated with survival after bladder cancer in spinal cord injury. J Spinal Cord Med 26 (2003) 339
7. Shokeir A.A. Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. BJU Int 93 (2004) 216
8. Vaidyanathan S., Mansour P., Soni B.M., et al. The method of bladder drainage in spinal cord injury patients may influence the histological changes in the mucosa of neuropathic bladder - a hypothesis. BMC Urol 2 (2002) 5
9. Khan M.S., Thornhill J.A., Gaffney E., et al. Keratinising squamous metaplasia of the bladder: natural history and rationalization of management based on review of 54 years of experience. Eur Urol 42 (2002) 469
10. Louie-Johnsun M.W., Braslis K.G., Murphy D.L., et al. Radical cystectomy for primary bladder malignancy: a 10 year review. ANZ J Surg 77 (2007) 265
11. Millar J.L., Frydenberg M., Toner G., et al. Management of muscle-invasive bladder cancer in Victoria, 1990-1995. ANZ J Surg 76 (2006) 113
12. Manunta A., Vincendeau S., Kiriakou G., et al. Non-transitional cell bladder carcinomas. BJU Int 95 (2005) 497
13. Chartier-Kastler E.J., Mozer P., Denys P., et al. Neurogenic bladder management and cutaneous non-continent ileal conduit. Spinal Cord 40 (2002) 443
14. Yalcin I., and Bump R.C. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 189 (2003) 98
15. Shabsigh A., Korets R., Vora K.C., et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 55 (2009) 164
16. Gerharz E.W., Mansson A., Hunt S., et al. Quality of life after cystectomy and urinary diversion: an evidence based analysis. J Urol 174 (2005) 1729
17. Hudes G., Carducci M., Tomczak P., et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 356 (2007) 2271
18. Hess M.J., Zhan E.H., Foo D.K., et al. Bladder cancer in patients with spinal cord injury. J Spinal Cord Med 26 (2003) 335
19. Pannek J. Transitional cell carcinoma in patients with spinal cord injury: a high risk malignancy?. Urology 59 (2002) 240
20. National Cancer Statistics Clearing House, Australian Institute of Health and Welfare. Canberra: AIHW 2007 (unpublished data).
21. Pagano F., Bassi P., Galetti T.P., et al. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 145 (1991) 45
22. Ghoneim M.A., el-Mekresh M.M., el-Baz M.A., et al. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J Urol 158 (1997) 393
23. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666
24. Navon J.D., Soliman H., Khonsari F., et al. Screening cystoscopy and survival of spinal cord injured patients with squamous cell cancer of the bladder. J Urol 157 (1997) 2109
25. Kantor A.F., Hartge P., Hoover R.N., et al. Urinary tract infection and risk of bladder cancer. Am J Epidemiol 119 (1984) 510
26. Kirkali Z., Chan T., Manoharan M., et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 66 (2005) 4
27. Razdan S., Leboeuf L., Meinbach D.S., et al. Current practice patterns in the urologic surveillance and management of patients with spinal cord injury. Urology 61 (2003) 893
28. Stonehill W.H., Goldman H.B., and Dmochowski R.R. The use of urine cytology for diagnosing bladder cancer in spinal cord injured patients. J Urol 157 (1997) 2112
29. Yang C.C., and Clowers D.E. Screening cystoscopy in chronically catheterized spinal cord injury patients. Spinal Cord 37 (1999) 204
30. Lotan Y., Capitanio U., Shariat S.F., et al. Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection. BJU Int 103 (2009) 1368